Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1036 AL 1050

A Review of the Current Status of Disease-Modifying Therapies and Prevention of Alzheimer's Disease

Parums DV.

Med Sci Monit. 2024 May 13;30:e945091. doi: 10.12659/MSM.945091.

Pharmacokinetic evaluation of donanemab for the treatment of Alzheimer's

Song T, Wang Y, Silverglate BD, Grossberg GT.

Expert Opin Drug Metab Toxicol. 2024 Jun;20(6):411-417. doi: 10.1080/17425255.2024.2357637. Epub 2024 May 20.

Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's disease: a meta-analysis of randomized controlled trials

Marinheiro G, Dantas JM, Mutarelli A, Menegaz de Almeida A, Monteiro GA, Zerlotto DS, Telles JPM.

Neurol Sci. 2024 Oct;45(10):4679-4686. doi: 10.1007/s10072-024-07576-8. Epub 2024 May 20.

Immunotherapy in Alzheimer's disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline

Azargoonjahromi A.

J Pharm Pharmacol. 2024 Sep 3;76(9):1115-1131. doi: 10.1093/jpp/rgae066.

Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer's Disease

Li J, Haj Ebrahimi A, Ali AB.

Int J Mol Sci. 2024 May 9;25(10):5169. doi: 10.3390/ijms25105169.

Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer's disease

Wang HJ, Chinna-Meyyappan A, Feldman OJ, Lanctôt KL.

Expert Opin Emerg Drugs. 2024 Sep;29(3):289-303. doi: 10.1080/14728214.2024.2363215. Epub 2024 Jun 11.

Development of disease-modifying therapies against Alzheimer's disease

Iwatsubo T.

Psychiatry Clin Neurosci. 2024 Sep;78(9):491-494. doi: 10.1111/pcn.13681. Epub 2024 Jun 6.

Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial

Ornish D, Madison C, Kivipelto M, Kemp C, McCulloch CE, Galasko D, Artz J, Rentz D, Lin J, Norman K, Ornish A, Tranter S, DeLamarter N, Wingers N, Richling C, Kaddurah-Daouk R, Knight R, McDonald D, Patel L, Verdin E, E Tanzi R, Arnold SE.

Alzheimers Res Ther. 2024 Jun 7;16(1):122. doi: 10.1186/s13195-024-01482-z.

Therapeutic Effects of Plant Anthocyanin against Alzheimer's Disease and Modulate Gut Health, Short-Chain Fatty Acids

Bayazid AB, Lim BO.

Nutrients. 2024 May 21;16(11):1554. doi: 10.3390/nu16111554.

Language impairments in Alzheimer´s disease: What changes can be found between mild and moderate stages of the disease?

Ortiz KZ, De Lira JO, Minett TSC, Bertolucci PHF.

Clinics (Sao Paulo). 2024 Jun 19;79:100412. doi: 10.1016/j.clinsp.2024.100412. eCollection 2024.

Emerging Therapeutic Potential of Fluoxetine on Cognitive Decline in Alzheimer's Disease: Systematic Review

Bougea A, Angelopoulou E, Vasilopoulos E, Gourzis P, Papageorgiou S.

Int J Mol Sci. 2024 Jun 13;25(12):6542. doi: 10.3390/ijms25126542.

Clinical Pipelines for Alzheimer's Disease Psychosis and Agitation

Oguma T, Jino K.

Chem Pharm Bull (Tokyo). 2024;72(7):610-617. doi: 10.1248/cpb.c23-00416.

Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon

Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Hadi NR, Assiri AA, Alrouji M, Welson NN, Alexiou A, Papadakis M, Batiha GE.

Cell Mol Neurobiol. 2024 Jul 8;44(1):55. doi: 10.1007/s10571-024-01489-y.

Acquired Risk Factors that Influence Risk for Dementia and Possibly Alzheimer Disease

Novak E, Tochtrop M, Schlagel D, Fuller W.

S D Med. 2024 Feb;77(2):87-90.

Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting

Sandoval KE, Witt KA.

Pharmacol Rev. 2024 Oct 16;76(6):1291-1325. doi: 10.1124/pharmrev.124.001117.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias